Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2020

Nov 10, 2020

SELL
$10.33 - $14.49 $21.2 Million - $29.8 Million
-2,054,294 Closed
0 $0
Q2 2020

Aug 10, 2020

BUY
$11.49 - $15.26 $3.52 Million - $4.67 Million
306,094 Added 17.51%
2,054,294 $28.7 Million
Q1 2020

May 12, 2020

BUY
$8.11 - $15.23 $671,508 - $1.26 Million
82,800 Added 4.97%
1,748,200 $20.6 Million
Q4 2019

Feb 10, 2020

BUY
$10.28 - $14.38 $4.29 Million - $6.01 Million
417,600 Added 33.47%
1,665,400 $23.6 Million
Q3 2019

Nov 12, 2019

BUY
$10.05 - $14.55 $1.64 Million - $2.38 Million
163,300 Added 15.06%
1,247,800 $13.2 Million
Q2 2019

Aug 13, 2019

BUY
$13.1 - $14.95 $8.68 Million - $9.9 Million
662,400 Added 156.93%
1,084,500 $15.8 Million
Q1 2019

May 13, 2019

SELL
$13.69 - $20.06 $6.57 Million - $9.62 Million
-479,700 Reduced 53.19%
422,100 $5.92 Million
Q4 2018

Feb 11, 2019

SELL
$13.96 - $18.26 $9.47 Million - $12.4 Million
-678,245 Reduced 42.93%
901,800 $15.7 Million
Q3 2018

Nov 13, 2018

BUY
$13.63 - $15.7 $3.89 Million - $4.48 Million
285,558 Added 22.06%
1,580,045 $24.1 Million
Q2 2018

Aug 13, 2018

SELL
$13.44 - $17.59 $941,646 - $1.23 Million
-70,063 Reduced 5.13%
1,294,487 $17.9 Million
Q1 2018

May 04, 2018

BUY
$13.8 - $16.99 $1.05 Million - $1.3 Million
76,400 Added 5.93%
1,364,550 $22.7 Million
Q4 2017

Feb 05, 2018

SELL
$11.73 - $14.75 $7.44 Million - $9.35 Million
-634,163 Reduced 32.99%
1,288,150 $18.3 Million
Q3 2017

Nov 06, 2017

BUY
$12.06 - $14.12 $23.2 Million - $27.1 Million
1,922,313
1,922,313 $27.1 Million

Others Institutions Holding INVA

About Innoviva, Inc.


  • Ticker INVA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 69,706,000
  • Market Cap $1.33B
  • Description
  • Innoviva, Inc. engages in the development and commercialization of pharmaceuticals in the United States and internationally. Its products include RELVAR/BREO ELLIPTA, a once-daily combination medicine consisting of a LABA, vilanterol (VI), an inhaled corticosteroid (ICS), and fluticasone furoate; ANORO ELLIPTA, a once-daily medicine combining a ...
More about INVA
Track This Portfolio

Track First Eagle Investment Management, LLC Portfolio

Follow First Eagle Investment Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of First Eagle Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on First Eagle Investment Management, LLC with notifications on news.